Biomarker Research in ADHD: the Impact of Nutrition
NCT03440346 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2019-07-01
Summary
Attention deficit hyperactivity disorder (ADHD) is the most common childhood behavioural disorder, causing significant impediment to a child's development. The exact aetiology of ADHD is still unknown. It is a complex disorder with numerous contributing (epi)genetic and environmental factors. Currently, treatment predominantly consists of behavioural and pharmacological therapy. However, medication use is associated with several side effects and concerns about long-term effects and efficacy exist. Therefore, there is considerable interest in the development of alternative treatment options.
Double-blind research investigating the effect of a few-foods diet (FFD) has demonstrated large improvements in ADHD symptoms. However, following an FFD requires great effort of both the child and parents. To make this treatment easier or potentially obsolete, it is important to understand how and in which children an FFD affects ADHD symptoms.
The investigators hypothesise that an FFD affects brain function and behaviour, including ADHD symptoms, via the complex network of communication between the microbiota, gut and brain, i.e. the MGB axis. The aim of this study is to identify potential mechanism(s) underlying the impact of an FFD on ADHD symptoms and to identify biomarkers that predict the response to the FFD.
100 boys with ADHD will follow the FFD for 5 weeks. After inclusion, all participants will start with a baseline period, during which they will maintain their regular diet. The baseline period ends at the end of week 2. Thereafter, participants will follow a 5-week FFD, preceded by a 1-week transition period. The FFD period ends at the end of week 8.
At the end of the baseline period (i.e. at the end of week 2) and at the end of the FFD (i.e. at the end of week 8), fMRI scans will be made, blood and buccal saliva will be collected, and stool and urine will be handed in. Children will do computer tasks and parents will complete questionnaires to monitor ADHD and physical complaints. All samples will be analysed by researchers blinded to behavioural responses to the FFD. To assess the impact of the FFD on brain function and the MGB axis, associations between ADHD behavioural changes and changes in other primary and secondary study outcomes will be analysed.
This study may lead to the identification of biomarkers that can predict the response to an FFD. Understanding which changes - induced by an FFD - lead to improvements in ADHD symptoms may provide new avenues for developing treatments. Ultimately, the findings may enable personalised intervention strategies based on an individuals' configuration of the MGB axis.
Conditions
- Attention Deficit-Hyperactivity Disorder
Interventions
- OTHER
-
Few-foods diet
The few-foods diet (FFD) is followed for 5-weeks preceded by a 1-week transition period during which the child's eating pattern will be gradually adjusted. The diet consists of rice, meat (turkey and lamb), a range of vegetables, pear, rice milk with added calcium and water, and is complemented with foods such as potatoes, fruits, corn, some sweets and wheat, which are allowed in small quantities only. Normal quantities of vegetables, rice and meat are allowed every day. If necessary the diet will be adjusted to avoid foods that the child dislikes or has cravings for. If the child does not respond to the initial FFD, i.e. no change in behaviour after the first two weeks, interim adjustments to the FFD will be made in consultation with the parents.
Sponsors & Collaborators
-
ADHD Research Centre
collaborator UNKNOWN -
Wageningen University
lead OTHER
Principal Investigators
-
Michiel Kleerebezem, Prof. dr. · Wageningen University
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 8 Years
- Max Age
- 10 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-19
- Primary Completion
- 2019-06-21
- Completion
- 2019-06-21
Countries
- Netherlands
Study Locations
More Related Trials
-
Attention-Deficit/Hyperactivity Disorder (ADHD) Brain Activity Changes to Psychostimulants
NCT01310439 ·Status: COMPLETED
-
Train Your Brain and Exercise Your Heart? Advancing the Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
NCT01363544 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Attention Deficit Hyperactivity Disorder: Nutrition and Environment
NCT02999503 ·Status: UNKNOWN ·Phase: NA
-
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
NCT00050622 ·Status: COMPLETED ·Phase: NA
-
Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study
NCT03252522 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Neurocognitive and Neurobiological Improvement in ADHD Children by Modification of Dietary Protein
NCT01856686 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)
NCT00483106 ·Status: COMPLETED ·Phase: PHASE4
-
Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers
NCT02623114 ·Status: UNKNOWN ·Phase: PHASE4
-
Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder
NCT02247986 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Biomarkers of ADHD Treatment Response
NCT05650775 ·Status: COMPLETED ·Phase: PHASE1
-
Identify Peripheral Biomarkers of Symptomatology, Neurocognitive Functions, and Medication Response in ADHD
NCT02074228 ·Status: UNKNOWN ·Phase: PHASE4
-
Event Rate and Effects of Stimulants in ADHD
NCT01913912 ·Status: WITHDRAWN ·Phase: PHASE3
-
The Safety and Efficacy of a Compound Natural Health Product in Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT01022229 ·Status: COMPLETED ·Phase: PHASE3
-
Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD
NCT02430896 ·Status: UNKNOWN
-
Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD
NCT03103750 ·Status: COMPLETED ·Phase: PHASE1
-
Neuroimaging the Expectancy Versus Pharmacotherapy Effect of Adderall on Cognitive Performance
NCT03530631 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Nutritional Formula Supplementation on Growth of Prepubertal Children Treated With Stimulants Medications for Attention Deficit Hyperactivity Disorder (ADHD)
NCT04962334 ·Status: RECRUITING ·Phase: NA
-
Nutrient Intake in Children With Attention Deficit Hyperactivity Disorder
NCT00011466 ·Status: UNKNOWN
-
Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity Disorder
NCT00143767 ·Status: UNKNOWN
-
Phase 3 Randomized Double-Blind Placebo-Controlled Study of NRP104 in Children Aged 6-12 With ADHD
NCT00556296 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life
NCT04943796 ·Status: COMPLETED
-
Motivated Behavior in Adults With and Without ADHD
NCT02630017 ·Status: COMPLETED ·Phase: PHASE2
-
Brain-Computer Interface (BCI) Based Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
NCT01344044 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Methylphenidate and Cognitive Training in Elderly
NCT03280251 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Controlled Study of Medical-education-community Collaborated Intervention in Children With ADHD
NCT04528433 ·Status: WITHDRAWN ·Phase: NA